Clinical Research Directory

Inclusion Criteria: * Patients with a prostate (either cis-male gender or trans-female gender with no prior hormone use at all). * Age 18 years or above. * Undergoing prostate biopsy as a result of an elevated serum PSA or abnormal digital rectal exam, who have undergone a pre-biopsy multi-parametric MRI and advised to undergo prostate biopsies. (Please note: the Calibration stage requires patients who have already undergone a biopsy and the pathology has been processed over the prior 0 to 12 months). Exclusion Criteria: * Unwilling or unable to give consent. * Any duration or type or dose of androgen deprivation therapy in the 6 months prior to screening. * Any prior radiotherapy to the prostate or pelvis (including the prostate) or ablation or chemical treatment of the prostate for treating cancer: these types of treatment affect the anatomy of prostate tissue microstructure for which Galen Prostate AI is not currently validated. NB: any treatment for benign enlargement of the prostate is permitted.